Population
Patients with liposarcoma, including various subtypes
Design
Review
Authors
Loading...
Molecular insights may expand liposarcoma treatment options; leaves open clinical validation before any practice change.
Advances in understanding the molecular and genetic basis of liposarcoma subtypes are guiding the development of targeted systemic therapies to complement traditional surgical and radiation management.
Nassif et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: